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Inversions
Over the past 5 years there has been a major drive in 
genomic research to identify submicroscopic structural 
variation  in  the  human  genome,  ranging  from  a  few 
hundred base pairs to approximately five megabases (Mb) 
in size. Structural variation is a term describing all forms 
of  rearrangements,  including  deletions,  duplications, 
insertions, inversions, translocations and more complex 
rearrangements. The main type of submicroscopic varia­
tion is copy number variation (CNV) [1,2], a term used to 
describe gains and losses of segments of DNA. The initial 
reports on CNVs as an abundant form of variation in the 
human genome were published in 2004 [3,4]. Since then, 
there have been multiple studies performed to charac­
terize the extent and importance of CNV in the human 
genome [5­14]. The majority of these studies have been 
based  on  microarrays,  either  as  comparative  genomic 
hybridization  (CGH)  arrays  or  single  nucleotide  poly­
mor  phism (SNP) arrays. Using array­based strategies, it 
is possible to identify unbalanced changes, that is, net 
gain or loss of large segments of DNA. However, other 
forms of variation involving a change in orientation or 
relocation  of  DNA,  without  any  gain  or  loss,  cannot 
readily  be  detected  with  arrays.  Therefore,  despite  the 
great  success  in  developing  human  genome  maps  of 
deletions and duplications, the mapping of inversions has 
lagged behind.
It is still not clear how many common inversions exist 
in  the  human  genome,  what  the  size  distribution  of 
inversions variants is, and to what extent inversions are 
associated with human disorders. With the recent intro­
duction of novel high­throughput sequencing techniques, 
the methodology is now available to screen for inversions 
in an unbiased manner. As a consequence, our under­
standing of the extent of inversion variants in the human 
genome has increased dramatically in the past few years. 
This  review  will  give  an  overview  of  the  current 
knowledge  of  inversions  in  the  human  genome,  the 
methods used to discover and type inversions, and their 
role in human disease and human genome architecture.
Cytogenetically visible inversions
It  has  long  been  possible  to  detect  inversions  of  large 
chromosomal regions in G­banded karyotypes. However, 
this strategy is limited to identification of variants that 
are  several  megabases  in  size,  and  even  significantly 
larger  inversions  may  escape  detection  if  the  inverted 
segment leads to little difference in the banding pattern. 
The long history of chromosomal studies in cytogenetics 
has led to the identification of several inversion variants, 
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have no clinical significance [15]. Inversions are the most 
common  human  constitutional  karyotype  aberration 
detected  in  cytogenetic  laboratories  [16].  Pericentric 
inversions are most frequent, often reported for chromo­
somes 1, 2, 3, 5, 9, 10 and 16. These are some of the most 
common  cytogenetically  visible  rearrangements  in 
humans  ­  for  example,  the  pericentric  inversion  of 
chromo  some 9 is found in over 1% of karyotypes [17]. 
However,  the  chromosome  9  variant  and  many  other 
commonly  identified  hetermorphisms  involve  only 
heterochromatic DNA.
The  most  frequently  observed  variant  that  includes 
euchromatic  sequence  is  the  inv(2)(p11q13),  which  is 
considered to be of no clinical significance [18]. Other 
events  are  rarer,  but  still  frequent  enough  to  be  seen 
regularly in cytogenetic screening, especially in specific 
population  groups.  In  addition  to  these  common 
variants, numerous rare and unique inversions have been 
observed in individuals with no apparent phenotype. An 
illustrative  example  is  inv(10)(q11.22q21.1),  a  12  Mb 
inversion  with  a  carrier  frequency  of  0.11%  in  the 
Swedish  population,  but  with  no  consistent  phenotype 
[19].  Breakpoint  and  haplotype  analysis  indicated  that 
this is a rare variant in the population, originating from a 
single  founder  event.  Due  to  the  balanced  nature  of 
inversions,  they  are  often  of  no  clinical  significance 
unless the breakpoint disrupts a gene or falls between a 
gene and its transcription regulatory elements. Excluding 
the well­established cytogenetically characterized variants, 
the rate of cytogenetically visible inversions reported is 
significantly lower than that of translocations. However, 
the exact rate of inversion formation is not known. A bias 
is likely in ascertainment of inversions in comparison to 
translocations, as balanced translocations lead to more 
reduced  fitness  by  increased  risk  for  an  unbalanced 
transmission to the offspring than inversions do. Balanced 
translocations are therefore commonly detected as part of 
investigations of reproductive difficulties, while inversions 
with no phenotypic effect may be transmitted through 
many generations and never be detected, as there may be 
no reason for cytogenetic screening.
One of the aspects that make inversions interesting as 
genomic rearrangements is their role in recent primate 
evolution.  Comparison  of  the  human  and  chimpanzee 
genomes shows that there are nine cytogenetically visible 
pericentric  inversions  [20]  and  many  submicroscopic 
inverted sequences [21]. The majority of the nine visible 
inversions  occurred  along  the  chimpanzee  lineage,  but 
inversions on chromosomes 1 and 18 are specific to the 
human  lineage.  These  findings  indicate  that  inversions 
are a type of rearrangement that occurs quite frequently 
in  primate  chromosomal  evolution.  Identification  of  a 
large  number  of  inversions  between  closely  related 
species, and signatures of selection associated with these, 
has  led  to  speculation  that  inversions  have  played  an 
important role in speciation [22].
Methods for inversion discovery and genotyping
Although  inversions  have  long  been  detectable  at  the 
resolution  of  cytogenetics,  progress  in  mapping  inver­
sions at the submicroscopic level is much more recent. 
As inversions only lead to a change in orientation, but 
not  in  copy  number,  they  cannot  be  detected  using 
hybridi  zation­based methods such as microarrays. Since 
most strategies to map structural variation in the human 
genome to date have been based on array approaches, 
there is comparatively little known about the distribution 
of inversions.
Although there has been a lack of methods for global 
discovery of inversions, it has long been possible to test 
for  the  presence  of  inversions  in  a  targeted  manner  if 
there is a prior hypothesis that a region may be inverted. 
Testing  can  be  done  using  traditional  molecular 
approaches such as pulse­field gel electrophoresis (PFGE) 
or Southern blot. Single molecular haplotyping has also 
been  successfully  used  to  screen  samples  for  specific 
inversion  variants  [23].  However,  these  strategies  are 
laborious and do not work for global unbiased discovery 
of new inversion regions on a genome­wide scale. Despite 
these limitations, a small number of studies have led to 
the  identification  of  inversion  variants  using  ’genomic‘ 
strategies. One approach that led to the identification of 
three polymorphic inversions was based on investigating 
regions  that  are  inverted  between  the  human  and 
chimpanzee  genomes.  By  targeting  23  such  regions  in 
human control samples, three inversions were found to 
be polymorphic in humans. In another study, Bansal et 
al. [24] used the linkage disequilibrium (LD) pattern of 
SNPs to map putative inversion breakpoints. By using a 
statistical  method  to  detect  regions  where  SNPs  at  a 
distance from each other on the reference assembly were 
in higher LD than SNPs in close proximity, a number of 
putative inversions were identified. Overlap with several 
previously validated inversions indicated that the approach 
was successful. However, the candidate variants identified 
by  this  method  require  experimental  validation  to 
distinguish real inversions from false positives. Although 
the approaches outlined above have shown some success 
in the discovery of novel inversion variants, recent data 
indicate that only a very small fraction of frequent human 
inversions were found.
A  major  breakthrough  in  the  discovery  of  inversions 
(and other forms of structural variation) came with the 
intro  duction of paired­end sequencing and mapping [7]. 
Generally, when the two ends of a cloned fragment are 
sequenced, the two resulting sequences would be expected 
to align to the reference genome in a + and ­ orientation, 
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inversion  as  compared  to  the  reference  assembly,  this 
would lead to the end sequences of fragments spanning 
the  breakpoints  to  align  in  a  ­/­  or  a  +/+  orientation 
(Figure  1).  By  searching  for  clusters  of  fragments 
exhibiting  this  pattern  of  alignments  to  the  reference 
assembly,  it  is  possible  to  identify  putative  inversion 
events. The first paired­end mapping study was based on 
end sequencing of fosmid clones using traditional Sanger 
sequencing [7]. The study identified 56 inversion break­
points from a fosmid library representing a single human 
genome (sample NA15510). The same strategy of fosmid 
end  sequencing  was  later  applied  to  another  eight 
genomes, and a total of 217 inversions were identified 
and validated [6]. A large number of inversions were also 
reported in the first individual genome to be sequenced 
(the genome of Craig Venter, called HuRef) [25]. Sanger 
sequencing  was  employed  to  sequence  the  HuRef 
genome,  and  an  assembly  was  created  independently 
from the National Center for Biotechnology Information 
(NCBI)  reference  assembly.  An  assembly  comparison 
analysis gave rise to 90 regions of inverted orientation 
between  the  HuRef  and  NCBI  assemblies.  Since  these 
initial Sanger sequencing studies, the general strategy of 
paired­end mapping has been adapted to fragment end­
sequencing with second­generation­sequencing platforms 
[26,27]. Although only a small number of whole­genome 
sequencing studies have so far employed this strategy to 
identify inversions, this is likely to be the main approach 
for identification of inversions in the near future.
Despite the success of paired­end mapping, there are 
still  challenges  to  overcome.  One  important  feature  of 
the paired­end mapping approach is that it relies on the 
reference  assembly.  It  is  well  established  that  the 
reference assembly represents very rare or unique alleles 
at some loci in the genome. In rare instances, it is also 
possible  that  these  unique  alleles  represent  cloning 
artifacts or are a result of mis­assembly of the reference 
sequence. For example, this has been suggested for an 
inversion  overlapping  an  exon  of  the  DOCK3  gene  on 
chromosome  3,  for  which  there  is  an  inversion  in  the 
reference  assembly  as  compared  to  available  mRNA 
Figure 1. Overview of inversion discovery by paired-end mapping. The top part of the figure shows the alignment between the reference 
assembly and an individual carrying an inversion. When paired-end mapping is performed, the donor DNA is first sheared into several similarly 
sized DNA fragments. The ends of these fragments are then sequenced (fragments are depicted in blue and red, with the boxes at the ends 
showing the parts that are sequenced). The pairs of end-sequences are then mapped to the reference genome. The majority of these pairs will 
map in a plus(+)/minus(-) orientation, separated by the approximate distance expected from the fragment size (labeled A and D). End-pairs labeled 
B and C indicate mapping of fragment ends in a region containing an inversion compared to the reference assembly. Instead of the expected 
+/- orientation of the two end-sequences, the pairs spanning the inversion breakpoints map as +/+ and -/-, respectively. Clusters of such read pairs 
are indicative of an inversion. Only fragments spanning the inversion breakpoint will exhibit this pattern of alignment. Better clone coverage will 
yield better resolution and more accurate mapping of the breakpoints.
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reference assembly harbors a unique allele, every study 
with high enough resolution and sequence coverage will 
identify a homozygous inversion.
Another limitation of paired­end mapping for inversion 
detection is related to the genome architecture associated 
with inversions. The majority of large (>100 kb) inver­
sions described in the human genome to date are flanked 
by  high  identity  segmental  duplications,  that  is, 
sequences >1 kb that exist in two or more copies of >90% 
identity  in  the  human  genome  [28,29].  The  segmental 
duplications associated with inversions cause problems 
for inversion discovery using paired­end mapping. As the 
method depends on alignment to the reference assembly, 
highly  identical  sequences  in  the  assembly  will  cause 
problems  in  identifying  unique  placements  for  the 
sequence  reads.  Many  paired­end  mapping  pipelines 
simply  discard  reads  that  cannot  be  uniquely  mapped. 
Therefore, the paired­end mapping strategy often fails to 
identify  inversions  flanked  by  long  inverted  segmental 
duplications of high identity. For these regions, targeted 
assays are required.
Current map of inversions in the human genome
The map of human inversions is still quite limited, and 
our understanding of the number of inversions, the size 
distribution and the frequency distribution is probably 
biased due to biases in the approaches used for variation 
identification. There are currently 914 inversion events 
reported  in  the  Database  of  Genomic  Variants  [30],  a 
database resource for structural variation in the human 
genome  [3,31].  However,  many  of  these  overlap  and 
actually refer to the same locus. If only non­redundant 
loci are counted, there are a total of 479 inversions in the 
database.  Figure  2  shows  an  overview  of  the  current 
inversions reported in the human genome. The inversions 
are  found  across  the  size  spectrum  up  to  several 
megabases.  A  comparison  of  the  size  distribution  of 
inversions  and  CNVs  is  shown  in  Figure  3.  The  size 
distribution shows that most of the inversions discovered 
to date are in the 10 kb to 100 kb interval. For CNVs, size 
distribution is shifted more towards smaller size variants.
There are many potential explanations for the differ­
ence in size distribution between inversions and CNVs 
(Figure 3). Biologically, large inversions are more likely to 
be  neutral,  without  obvious  phenotypic  consequences, 
compared to large CNVs. Data from cytogenetic studies 
support  this.  One  difference  between  inversions  and 
CNVs is that the genes within an inversion can be entirely 
unaffected, while genes within CNVs are always affected 
by a dosage imbalance. For inversions, it is more impor­
tant  where  the  breakpoints  are  located  and  if  these 
interrupt a gene or lead to disruption of the transcrip­
tional  regulation  of  genes.  If  no  gene  or  regulatory 
function  is  interrupted  by  the  breakpoints,  inversions 
that  are  comparatively  large  may  be  frequent  in  the 
population. While there are very few CNVs >1 Mb in size 
that have reached a minor allele frequency of 1%, there 
are examples of very large inversions that are frequently 
observed in the population. The best­studied examples 
are  two  inversions  located  on  chromosomes  4  and  8, 
respectively. Both these inversions have breakpoints that 
Figure 2. Distribution of inversion variants in the human 
genome. The blue lines in this ideogram show the human 
chromosomal distribution of the 479 non-redundant inversion 
variants reported in the Database of Genomic Variants.
Figure 3. Size distribution of inversions and copy number 
variants. The size distribution of inversions reported in the 
Database of Genomic Variants (a) shows that the majority of 
inversions reported to date are in the 10 to 100 kb size bin. The 
size distribution of inversions differs from that reported for copy 
number variants (CNVs) (b) The CNV data plotted here show the 
11,700 non-redundant CNV events reported by Conrad et al. [13]. It is 
currently unclear whether the difference in size distribution between 
inversions and CNVs is due to ascertainment bias, or whether there is 
an actual biological difference in size distribution. Both cytogenetic 
data and evolutionary comparative genomic data indicate that large 
inversions are less detrimental than large deletions and duplications.
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inversion on chromosome 8 is approximately 3.5 Mb in 
size  and  has  been  reported  to  be  present  in  26%  of 
healthy  controls,  while  the  chromosome  4  inversion  is 
about 6 Mb in size and was found in 12.5% of healthy 
controls [32]. These data indicate that very large inver­
sions may exist in the human genomes without a strong 
negative effect on reproductive fitness.
There may also be a methodological explanation for the 
difference  in  size  distribution  between  current  anno­
tations of inversions and CNVs, based on differences in 
methods of discovery and limitations in technology. The 
size  distribution  for  inversions  is  reflective  of  the 
resolution and limited sequence coverage of the paired­
end mapping projects published to date. For very small 
inversions, deep sequence coverage would be required to 
obtain several DNA fragments spanning one breakpoint. 
Therefore, many additional inversions will be found as 
thousands of additional genomes are sequenced over the 
next few years, and a large fraction of these would be 
expected  to  increase  the  fraction  of  variants  that  are 
<10 kb in size.
Finally, it is also possible that the size distribution for 
inversions  differs  from  that  of  CNVs  based  on  the 
mechanisms  by  which  the  variants  are  created.  As  for 
CNVs [13], it is likely that different mechanisms act across 
the  size  spectrum  and  give  rise  to  larger  and  smaller 
inversion events, respectively. Through non­allelic homo­
lo  gous  recombination  (NAHR)  ­  recombina  tion  events 
taking place between highly similar sequences ­ regions 
located between segmental duplications or highly identical 
repeat sequences may be deleted, duplicated or inverted. 
Inversions can be formed by this process if the duplicated 
sequences are in inverted orientation with respect to each 
other.  Therefore,  NAHR  is  considered  the  primary 
mechanism by which large (tens of kilobases) inversions 
are formed. However, for small inversions, the mechanisms 
are  not  as  well  characterized  as  for  smaller  insertions/
deletions. Some evidence points towards replication­based 
mechanisms,  such  as  microhomology­mediated  break­
induced  replication  (MMBIR)  [33].  Other  specific 
mechanisms that have been suggested to be involved in 
creation of inversions include fork stalling and template 
switching (FoSTeS) [34] and serial replica  tion slippage in 
trans [35]. However, the limited number of inversions with 
nucleotide resolution breakpoint information available to 
date  has  prevented  a  thorough  investigation  of 
mechanisms and sequence motifs giving rise to inversions. 
As additional inversion breakpoints are identified, these 
relationships should become more evident.
Inversions in human disorders
There are many descriptions in the literature of patients 
with specific phenotypes who also carry an inversion that 
is cytogenetically visible. Since inversions are relatively 
rare events, and it is unlikely that multiple patients with 
the same inversion are found, it is often problematic to 
assess  whether  the  inversion  present  in  the  patient  is 
actually associated with the phenotype. The exception is 
if the inversion breakpoint falls within or near a gene that 
has previously been associated with the disorder through 
other types of mutations. For recurrent inversions, the 
association  between  phenotype  and  genotype  is  more 
obvious, and a number of such loci have been described. 
One of the best­characterized recurrent inversions giving 
rise to disease causes hemophilia A, an X­linked disorder 
caused  by  mutations  in  the  factor  VIII  gene  [36].  A 
recurrent inversion has been found in approximately 43% 
of patients [37]. Molecular characterization of the break­
points  indicates  that  the  inversion  is  a  result  of  intra­
chromosomal  homologous  recombination,  originating 
almost  exclusively  in  male  germ  cells.  This  recurrent 
inversion spans approximately 400 kb and is mediated by 
two  inverted  segmental  duplications,  one  of  which  is 
located  in  intron  22  of  the  factor  VIII  gene,  with  two 
other  copies  being  located  approximately  400  kb  telo­
meric  to  the  gene.  Other  examples  where  recurrent 
inver  sions have been shown to lead to a disease pheno­
type  are  the  disruption  of  the  idunorate  2­sulphatase 
gene in mucopolysaccharidosis type II (Hunter syndrome) 
[38],  and  disruption  of  the  emerin  gene  in  Emery­
Dreifuss muscular dystrophy [39].
A  specific  category  of  inversions  associated  with 
genetic disorders is those that are not directly causative, 
but  rather  increase  the  risk  of  further  rearrangements 
that cause disease. For a number of microdeletion syn­
dromes,  one  or  both  parents  of  probands  have  been 
found to carry an inversion of the deleted interval. The 
association  was  first  described  in  Williams­Beuren 
syndrome, which is most commonly caused by a 1.5 Mb 
microdeletion at 7q11. In a study of 12 families where the 
proband carried the typical microdeletion, an inversion 
was found in a parent for 33% of the patients [40]. The 
inversion variant has since been shown to be relatively 
frequent in the general population (approximately 5%), 
and does not seem to be associated with a phenotype in 
itself [41].
Another example of a disorder where an inversion has 
been associated with a causative deletion is the 17q21.31 
microdeletion syndrome, a genetically characterized form 
of  mental  retardation.  This  region  harbors  a  970  kb 
inversion  polymorphism  found  at  high  frequency  in 
European populations [42]. The genetic variation pattern 
within  the  region  indicates  that  the  inversion  first 
appeared before dispersal out of Africa, and that there 
has been little or no recombination between the haplo­
types.  Interestingly,  there  is  some  evidence  that  this 
inversion variation is associated with higher reproductive 
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retarda  tion  led  to  the  discovery  of  a  microdeletion 
syndrome  corresponding  to  the  same  region  as  the 
common inversion polymorphism [43­45]. Studies of the 
parents of microdeletion carriers showed that at least one 
parent carried the inverted H2 haplotype in every case. It 
was  therefore  initially  concluded  that  the  inversion  in 
itself was the cause of the increased risk for the deletion 
to occur. It has been suggested that the lack of homology 
across  the  inversion  region  between  heterozygous 
chromatids in meiosis may lead to the formation of an 
‘asynaptic bubble’ that renders the region unstable and 
prone to additional rearrangements [46]. However, addi­
tional characterization of the prevalent haplotypes in the 
region  indicates  that  other  rearrangements  present  on 
the inverted H2 haplotype may be the primary substrate 
for the non­allelic homologous recombination giving rise 
to  the  microdeletion  [47].  Additional  studies  will  be 
needed to confirm exactly how the inversion leads to an 
increased risk for deletions in the offspring.
In total, there are at least nine different microdeletion 
syndromes for which the deletion region has also been 
found as an inversion variant in the general population 
(Table  1).  For  a  majority  of  these  disorders,  a  direct 
association  between  the  inversion  carrier  status  and 
increased  risk  for  deletion  in  the  offspring  has  been 
established  by  comparing  the  inversion  frequency  in 
parents  to  the  frequency  in  the  general  population. 
However, the exact molecular mechanisms still remain to 
be elucidated and it is not confirmed whether it is the 
inversion itself, or other sequence features present on the 
inversion  haplotype,  that  causes  the  subsequent 
pathogenic rearrangement.
Conclusions and future perspectives
With the advent of deep coverage paired­end sequencing, 
the  number  of  inversions  reported  has  increased 
dramatically  and  the  inversion  breakpoints  will  be 
pinpointed at much higher resolution. Over the next year 
or two, the true extent of inversion variants in the human 
genome will be revealed. Only then will it be possible to 
explore  the  contribution  of  inversions  to  common 
disease. For both inversions and other structural variants, 
it has been anticipated that it would be possible to impute 
these  variants  from  high­density  SNP  array  data. 
However, recent studies indicate that this may not be the 
case.  Data  from  one  study  show  that  many  large 
inversions,  surrounded  by  blocks  of  segmental 
duplications,  have  arisen  on  more  than  one  haplotype 
background [48]. Similar data have been shown for multi­
allelic CNVs [13]. These variants will therefore need to be 
directly  targeted  for  inclusion  in  association  studies. 
Currently, the experimental strategies for accurate high­
throughput  genotyping  of  inversions  and  multi­allelic 
CNVs  are  limited  or  non­existent.  However,  it  is  very 
likely  that  smaller  inversions  that  are  not  flanked  by 
blocks  of  segmental  duplications  will  have  arisen  only 
once and will therefore be in LD with surrounding SNPs. 
This has been shown in a limited number of cases [21], 
but more data are needed to confirm whether this applies 
to a majority of events. Other questions that remain to be 
explored  in  further  detail  include  inversion  formation 
mechanisms,  characterization  of  breakpoints,  and 
development  of  maps  and  strategies  for  inclusion  of 
inversion  variants  in  genome­wide  disease  association 
studies. In conclusion, we are now at the stage where we 
have  the  tools  that  enable  characterization  of  the  full 
extent  of  inversions  in  the  human  genome  and  their 
contribution to human variation and disease.
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Table 1. Rearrangements associated with inversion variants
Chromosome band  Inversion size (Mb)  Disorder/rearrangement  Reference (syndrome : inversion)
3q29  1.9  3q29 deletion syndrome  [49] : [7]
5q35.2-q35.3*  1.9  Sotos syndrome microdeletion  [50] : [51]
7q11.23*  1.5  Williams-Beuren syndrome microdeletion  [52] : [40]
8p23a  4.7  Inv dup(8p) and del (8)(p23.1;p23.2)  [53,54] : [32,55] 
15q11-q13*  4  Angelman syndrome deletion  [56] : [57]
15q13.3*  2  15q13.3 microdeletion  [58] : [6,58]
15q24  1.2  15q24 microdeletion  [44,59] : [6]
17q12  1.5  Renal cysts and diabetes (RCAD) microdeletion syndrome  [60] : [6]
17q21.31*  0.9  17q21.31 microdeletion syndrome  [43-45] : [42]
aThe inversion has been found at higher frequency in parents of probands with microdeletions than in the general population, indicating that the inversion is a risk 
factor for subsequent rearrangements in the offspring.
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